| | COMPOUND: C07650 | |
Entry |
|
Name |
|
Formula |
C9H11F2N3O4
|
Exact mass |
263.0718
|
Mol weight |
263.1981
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC05 Gemcitabine
D02368 Gemcitabine (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01439 Arabinofuranosyl type antineoplastic
DG00688 Gemcitabine
D02368 Gemcitabine
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Ribonucleoside-diphosphate reductase
RRM1
D02368 Gemcitabine (USAN/INN)
|
Other DBs |
|
KCF data |
ATOM 18
1 C1y C 19.0421 -17.4316
2 N4y N 20.4400 -16.3827
3 C1z C 18.6921 -18.7617
4 O2x O 17.9220 -16.5915
5 C8y C 21.6273 -17.0180
6 C8x C 20.4260 -15.0045
7 C1y C 17.2220 -18.7617
8 X F 18.6921 -20.1618
9 X F 19.9522 -18.7617
10 C1y C 16.8019 -17.4316
11 N5x N 22.7768 -16.1969
12 O5x O 21.6331 -18.2800
13 C8x C 21.5755 -14.1834
14 O1a O 16.3819 -19.8118
15 C1b C 15.6118 -17.0116
16 C8y C 22.7628 -14.8187
17 O1a O 14.5617 -18.0616
18 N1a N 23.9242 -14.0367
BOND 19
1 1 2 1 #Up
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 3 9 1
9 4 10 1
10 5 11 1
11 5 12 2
12 6 13 2
13 7 14 1 #Down
14 10 15 1 #Up
15 11 16 2
16 15 17 1
17 16 18 1
18 7 10 1
19 13 16 1
|
|
» Japanese version
|
|